Asia Pacific Cryptococcosis Market Size & Outlook, 2026-2034


Asia Pacific Cryptococcosis Market Insights

  • Based on Reed Intelligence findings, the Asia Pacific Cryptococcosis Market size reached USD 117.49 Million in 2025 and is expected to grow to USD 210.05 Million by 2034.
  • During 2026–2034, the market is forecasted to advance at a CAGR of 6.69%.
  • Azoles represented the largest share of the By Drug Class market in terms of size in 2025.
  • Among the By Drug Class segments, Polyenes is forecasted to achieve the highest growth and remain the most lucrative through the forecast period.

Other Key Findings


  • In 2025, Asia Pacific accounted for 17.28% of the global Cryptococcosis Market size.
  • By 2034, United States is projected to lead the global market in terms of market size.
  • India is projected to emerge as the fastest-growing market in Asia Pacific, reaching USD 38.4 Million by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 117.49 Million
Market Size In 2034 USD 210.05 Million
Largest segment Azoles
Units Revenue in USD Million
CAGR 6.69% (2026-2034)
Segmnetation Covered
Asia Pacific
  1. China
  2. India
  3. Japan
  4. South Korea
  5. Taiwan
  6. Australia
  7. Singapore
  8. South East Asia
By Drug Class
  1. Azoles
  2. Polyenes
  3. Flucytosine
  4. Combination Therapy
By Indication
  1. Cryptococcal Meningitis
  2. Pulmonary Cryptococcosis
  3. Disseminated Cryptococcosis
By Route of Administration
  1. Oral
  2. Intravenous
By End-Use
  1. Hospitals
  2. Specialty Clinics
  3. Research Institutes
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends